A novel zwitterionic bioceramic with dual antibacterial capability

Area of Science:

• Biomaterials Science
• Nanotechnology
• Infectious Diseases

Background:

• Bone implant infections pose a significant clinical challenge, often requiring effective antibacterial strategies.
• Current treatments struggle with antibiotic resistance and biofilm formation.
• Developing novel bioceramics with inherent antibacterial properties is crucial.

Purpose of the Study:

• To synthesize a novel zwitterionic SBA-15 bioceramic with dual antibacterial capabilities.
• To investigate the structural, textural, and surface properties of the synthesized material.
• To evaluate the antibiofouling and antibiotic delivery potential for bone infections.

Main Methods:

• Co-condensation synthesis of zwitterionic SBA-15 functionalized with amine groups.
• Characterization using XRD, HR-TEM, N2 adsorption porosimetry, FTIR, solid-state NMR, STEM-EDS, and ζ-Potential measurements.
• In vitro bacterial adhesion assays with Staphylococcus aureus and cephalexin release studies.

Main Results:

• The synthesized zwitterionic SBA-15 retained structural and textural properties of pure silica SBA-15.
• Zwitterionic pairs (-NH3⊕/-SiO⊖ and >NH2⊕/-SiO⊖) were confirmed on the surface and stable at physiological pH.
• The material demonstrated 99.9% inhibition of bacterial adhesion and sustained release of cephalexin.

Conclusions:

• The novel zwitterionic SBA-15 bioceramic exhibits significant antibiofouling and bactericidal properties.
• Its ability to prevent bacterial adhesion and deliver antibiotics makes it a promising candidate for bone implant infection treatment.
• This dual-action material offers a new therapeutic avenue for combating implant-associated infections.